Statistical evaluation of surrogate endpoints with examples from cancer clinical trials
From MaRDI portal
Publication:2792764
DOI10.1002/BIMJ.201400049zbMath1403.62196OpenAlexW1814296497WikidataQ38356102 ScholiaQ38356102MaRDI QIDQ2792764
Marc Buyse, Koji Oba, Tomasz Burzykowski, Xavier Paoletti, Wim Van Der Elst, Ariel Alonso, Geert Molenberghs
Publication date: 14 March 2016
Published in: Biometrical Journal (Search for Journal in Brave)
Full work available at URL: https://lirias.kuleuven.be/handle/123456789/489613
Related Items (4)
An efficient algorithm to assess multivariate surrogate endpoints in a causal inference framework ⋮ Binary surrogates with stratified samples when weights are unknown ⋮ Proportion of treatment effect mediated by surrogate endpoints ⋮ Handling missing within‐study correlations in the evaluation of surrogate endpoints
Uses Software
Cites Work
- Unnamed Item
- Validation of Surrogate end Points in Multiple Randomized Clinical Trials with Failure Time end Points
- A Mathematical Theory of Communication
- Choice of units of analysis and modeling strategies in multilevel hierarchical models
- Center-within-trial versus trial-level evaluation of surrogate endpoints
- Comparative assessment of trial-level surrogacy measures for candidate time-to-event surrogate endpoints in clinical trials
- The evaluation of surrogate endpoints.
- Principal Stratification in Causal Inference
- Prentice's Approach and the Meta-Analytic Paradigm: A Reflection on the Role of Statistics in the Evaluation of Surrogate Endpoints
- On the relationship between the causal‐inference and meta‐analytic paradigms for the validation of surrogate endpoints
- A Bayesian Approach to Surrogacy Assessment Using Principal Stratification in Clinical Trials
- Validation of a longitudinally measured surrogate marker for a time-to-event endpoint
- Related Causal Frameworks for Surrogate Outcomes
- Survival models for heterogeneous populations derived from stable distributions
- A model for association in bivariate life tables and its application in epidemiological studies of familial tendency in chronic disease incidence
- Inferences on the Association Parameter in Copula Models for Bivariate Survival Data
- Simplified hierarchical linear models for the evaluation of surrogate endpoints
- The validation of surrogate endpoints in meta-analyses of randomized experiments
- On meta-analytic assessment of surrogate outcomes
- Criteria for the Validation of Surrogate Endpoints in Randomized Experiments
- General class of covariance structures for two or more repeated factors in longitudinal data analysis
- Modelling Progression of CD4-Lymphocyte Count and Its Relationship to Survival Time
- Surrogate Marker Evaluation from an Information Theory Perspective
This page was built for publication: Statistical evaluation of surrogate endpoints with examples from cancer clinical trials
